BioRestorative Therapies enters revolving credit facility agreement dated June 10, 2026
BioRestorative Therapies, Inc. executed a revolving loan agreement with an unnamed lender providing access to capital on an as-needed basis up to a maximum outstanding amount. The facility provides financial flexibility for the biotech company's operational and strategic needs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day